Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc. (Nasdaq: PWUP) is a blank check company incorporated to identify and consummate a business combination in the biopharmaceutical sector. The company filed a Form 10-Q with the Securities and Exchange Commission on November 10, 2022, under accession number 0001410578-22-003172, reflecting its continued status as a publicly reporting SPAC at that point in its lifecycle. Focused on the life sciences and biopharma industry, PWUP represents one of numerous healthcare-targeted SPACs that came to market during the elevated SPAC issuance period of the early 2020s. Sign up for SpacDesk to access full filing history, sponsor details, timeline data, and deal status for PWUP and hundreds of other SPACs.